The Department of the Army Medical Command awarded a $3,309,999.00 Project Grant to Moonlight Therapeutics, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective July 1, 2025 through June 30, 2028, will support the development of a peanut allergy treatment for adults using microneedle technology. This research initiative aims to transform healthcare for military service members and the broader public by investigating innovative medical solutions. The federal grant program funds a range of advanced biomedical research across multiple disciplines, with a focus on conditions relevant to the military. Moonlight Therapeutics, a minority-owned for-profit organization, will lead this project focused on developing a novel peanut allergy treatment.
Generated 7/8/25, 1:50 AM